Syngene Appoints VWR International as New Canadian Distributor
News Mar 28, 2013
Syngene, a world-leading manufacturer of image analysis solutions is delighted to announce that it is strengthening its Canadian presence with the appointment of respected distributors, VWR International, allowing life scientists in Canada to easily access Syngene’s unrivalled image analysis technology.
Syngene has appointed VWR International to market its equipment in Canada because the firm is an established manufacturer’s representative with specialist knowledge of image analysis. VWR has a network of 60 scientific sales professionals and 6 life science specialists who will provide sales and technical support for Syngene’s high quality gel documentation and image analyzer range, which includes Syngene’s latest PXi systems for imaging and analyzing DNA and protein gels.
Michael Ratos, Vice President of Marketing Canada, VWR International commented: “We always look to offer best in class products for our customers and the Syngene image analysis systems are exactly that. The image analyzers offer the best value for money and perfectly complement the other products we provide for DNA and protein analysis so we’re delighted to add them to our product portfolio.”
Ratos added: “We are especially impressed with the PXi range of image analyzers because they are cost-competitive. The GeneSys software which comes with the PXi is user friendly, which means it is quick and easy to set up and demonstrate to life scientists. The support we have had from Syngene’s technical team has been fabulous and their training has helped us really understand the products. We’re looking forward to a long association with Syngene.”
Laura Sullivan, Syngene’s Divisional Manager concluded: "We have had great success recently in the North American market with our image analyzers and are supporting this growth by adding VWR’s extensive network of technical specialists to our team. VWR is a first-class distributor and we know that through their professional approach, Syngene’s excellent reputation for delivering performance and service will be extended to all our existing and potential Canadian life science clients.”
MIT researchers have developed a cryptographic system that could help neural networks identify promising drug candidates in massive pharmacological datasets, while keeping the data private. Secure computation done at such a massive scale could enable broad pooling of sensitive pharmacological data for predictive drug discovery.
The architecture of each person’s brain is unique, and differences may influence how quickly people can complete various cognitive tasks.o learn more, scientists are developing a new tool — computational models of the brain — to simulate how the structure of the brain may impact brain activity and, ultimately, human behavior.READ MORE
8th Edition of International Conference and Exhibition on Separation Techniques
Jul 29 - Jul 30, 2019